Skip to main navigation Skip to search Skip to main content

The monocrotaline model of pulmonary hypertension in perspective

  • Jose G. Gomez-Arroyo
  • , Laszlo Farkas
  • , Aysar A. Alhussaini
  • , Daniela Farkas
  • , Donatas Kraskauskas
  • , Norbert F. Voelkel
  • , Harm J. Bogaard

Research output: Contribution to journal › Review article › peer-review

Abstract

Severe forms of pulmonary arterial hypertension (PAH) are characterized by various degrees of remodeling of the pulmonary arterial vessels, which increases the pulmonary vascular resistance and right ventricular afterload, thus contributing to the development of right ventricle dysfunction and failure. Recent years have seen advances in the understanding of the pathobiology of PAH; however, many important questions remain unanswered. Elucidating the pathobiology of PAH continues to be critical to design new effective therapeutic strategies, and appropriate animal models of PAH are necessary to achieve the task. Although the monocrotaline rat model of PAH has contributed to a better understanding of vascular remodeling in pulmonary hypertension, we question the validity of this model as a preclinically relevant model of severe plexogenic PAH. Here we review pertinent publications that either have been forgotten or ignored, and we reexamine the monocrotaline model in the context of human forms of PAH.

Original languageEnglish
Pages (from-to)L363-L369
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume302
Issue number4
DOIs
StatePublished - Feb 2012

Keywords

  • Acute lung injury
  • Hepatic venocclusive disease
  • Monocrotaline
  • Myocarditis
  • Pulmonary hypertension

Fingerprint

Dive into the research topics of 'The monocrotaline model of pulmonary hypertension in perspective'. Together they form a unique fingerprint.

Cite this